RecruitingPhase 2NCT07364786

Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma

Studying Embryonal tumor of neuroepithelial tissue

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peter Siesjö
Principal Investigator
Peter Siesjö, MD, PhD
Skane University Hospital
Intervention
Salovum(dietary_supplement)
Enrollment
10 target
Eligibility
18-75 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

Lund University · Region Skane

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07364786 on ClinicalTrials.gov

Other trials for Embryonal tumor of neuroepithelial tissue

Additional recruiting or active studies for the same condition.

See all trials for Embryonal tumor of neuroepithelial tissue

← Back to all trials